Deutsche Bank
DNTH icon

Deutsche Bank’s Dianthus Therapeutics DNTH Stock Holding History

Deutsche Bank’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6M Sell
68,117
-1,639
-2% -$170K ﹤0.01% 1164
2026
Q2 		$6.8M Buy
69,756
+38,296
+122% +$3.34M ﹤0.01% 1210
2026
Q1 		$2.64M Buy
31,460
+15,629
+99% +$905K ﹤0.01% 1632
2025
Q4 		$652K Buy
15,831
+1,343
+9% +$52.1K ﹤0.01% 2427
2025
Q3 		$570K Hold
14,488
– – ﹤0.01% 2479
2025
Q2 		$270K Sell
14,488
-3,408
-19% -$63.9K ﹤0.01% 2796
2025
Q1 		$325K Sell
17,896
-2,115
-11% -$46.6K ﹤0.01% 2710
2024
Q4 		$436K Buy
20,011
+7,179
+56% +$185K ﹤0.01% 2679
2024
Q3 		$351K Buy
12,832
+3,363
+36% +$93.7K ﹤0.01% 2647
2024
Q2 		$245K Buy
+9,469
New +$228K ﹤0.01% 2691
2022
Q2 		– Sell
-1,087
Closed -$50K – 4169
2022
Q1 		$50K Sell
1,087
-121
-10% -$6.61K ﹤0.01% 3843
2021
Q4 		$85K Buy
1,208
+60
+5% +$6.03K ﹤0.01% 3771
2021
Q3 		$133K Sell
1,148
-34
-3% -$3.96K ﹤0.01% 3765
2021
Q2 		$185K Buy
1,182
+267
+29% +$49K ﹤0.01% 3828
2021
Q1 		$174K Sell
915
-79
-8% -$13.3K ﹤0.01% 3710
2020
Q4 		$125K Buy
994
+273
+38% +$31K ﹤0.01% 3725
2020
Q3 		$79K Buy
721
+161
+29% +$19.1K ﹤0.01% 3658
2020
Q2 		$68K Buy
560
+100
+22% +$14.1K ﹤0.01% 3649
2020
Q1 		$46K Buy
460
+21
+5% +$3.89K ﹤0.01% 3581
2019
Q4 		$105K Buy
439
+98
+29% +$18.3K ﹤0.01% 3555
2019
Q3 		$55K Sell
341
-29
-8% -$5.51K ﹤0.01% 3880
2019
Q2 		$87K Sell
370
-647
-64% -$160K ﹤0.01% 4270
2019
Q1 		$266K Buy
1,017
+895
+734% +$154K ﹤0.01% 3831
2018
Q4 		$10K Sell
122
-449
-79% -$61.2K ﹤0.01% 4868
2018
Q3 		$110K Sell
571
-679
-54% -$143K ﹤0.01% 4466
2018
Q2 		$270K Buy
+1,250
New +$282K ﹤0.01% 4151

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank's DNTH Position: Q3 2026 in Review

Deutsche Bank reduced its Dianthus Therapeutics (DNTH) stake by 2.3% in Q3 2026, selling an estimated $170K and leaving 68,117 shares worth $6M. The position accounts for ﹤0.01% of the portfolio, ranked #1164.

Deutsche Bank first reported a position in DNTH in Q2 2018 and has held it in 26 quarters since. The position peaked at $6.8M in Q2 2026. 109 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Deutsche Bank held 68,117 shares of Dianthus Therapeutics worth $6M as of Q3 2026.
  • Deutsche Bank sold 1,639 Dianthus Therapeutics shares in Q3 2026, an estimated $170K.
  • Dianthus Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1164 holding.
  • Deutsche Bank first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 26 quarters since.
  • Deutsche Bank's Dianthus Therapeutics position peaked at $6.8M in Q2 2026.
  • 109 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.